173 related articles for article (PubMed ID: 15976800)
1. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.
van der Horst IC; De Luca G; Ottervanger JP; de Boer MJ; Hoorntje JC; Suryapranata H; Dambrink JH; Gosselink AT; Zijlstra F; van 't Hof AW
Am Heart J; 2005 Jun; 149(6):1135. PubMed ID: 15976800
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
Bucciarelli-Ducci C; Bianchi M; De Luca L; Battagliese A; Di Russo C; Proietti P; Vizza CD; Fedele F
Am J Cardiol; 2006 Nov; 98(10):1349-53. PubMed ID: 17134627
[TBL] [Abstract][Full Text] [Related]
3. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
Rasoul S; Ottervanger JP; Timmer JR; Svilaas T; Henriques JP; Dambrink JH; van der Horst IC; Zijlstra F
Int J Cardiol; 2007 Oct; 122(1):52-5. PubMed ID: 17223212
[TBL] [Abstract][Full Text] [Related]
4. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
7. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
[TBL] [Abstract][Full Text] [Related]
8. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial.
Lefèvre T; Garcia E; Reimers B; Lang I; di Mario C; Colombo A; Neumann FJ; Chavarri MV; Brunel P; Grube E; Thomas M; Glatt B; Ludwig J;
J Am Coll Cardiol; 2005 Jul; 46(2):246-52. PubMed ID: 16022950
[TBL] [Abstract][Full Text] [Related]
9. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
[TBL] [Abstract][Full Text] [Related]
10. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
[TBL] [Abstract][Full Text] [Related]
11. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
12. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ST-segment resolution after rescue percutaneous coronary intervention. Data from the RICO survey.
Lorgis L; Zeller M; Dentan G; Laurent Y; Taam JA; L'Huillier I; Vincent-Martin M; Makki H; Cottin Y;
Catheter Cardiovasc Interv; 2008 Apr; 71(5):607-12. PubMed ID: 18360851
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
Yazici M; Demircan S; Durna K; Yasar E; Acar Z; Sahin M
Am J Cardiol; 2005 Dec; 96(11):1517-20. PubMed ID: 16310433
[TBL] [Abstract][Full Text] [Related]
16. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
Uyarel H; Cam N; Okmen E; Kasikcioglu H; Tartan Z; Akgul O; Simsek D; Cetin M; Bozbeyoglu E; Buturak A; Uzunlar B
Am Heart J; 2006 Jun; 151(6):1239.e1-7. PubMed ID: 16781226
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
[TBL] [Abstract][Full Text] [Related]
18. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
[TBL] [Abstract][Full Text] [Related]
19. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
